ChemoCentryx, Inc. (CCXI)

Oncology Corporate Profile

Stock Performance

6.8400
0.0200

HQ Location

850 Maude Avenue
Mountain View, CA 94043

Company Description

ChemoCentryx, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics that target the chemokine and chemoattractant systems in order to treat autoimmune diseases, inflammatory disorders and cancer.

Website: http://www.chemocentryx.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
CCX872CCR2 inhibitorPancreatic cancerII
CCR2PD-L1 inhibitorVarious cancer typesPreclinical
CCR1PD-L1 inhibitorVarious cancer typesPreclinical
CCR5PD-L1 inhibitorVarious cancer typesPreclinical
CXCR2PD-L1 inhibitorVarious cancer typesPreclinical

View additional information on product candidates here »

Source: http://www.chemocentryx.com

Recent News Headlines

8/21/2017 06:18 am

8/21/2017 06:18 am

8/21/2017 06:18 am

8/21/2017 06:18 am

8/10/2017 12:17 pm

8/10/2017 06:17 am

8/10/2017 06:17 am

8/10/2017 06:17 am

8/10/2017 06:17 am

8/9/2017 12:17 am

8/9/2017 12:17 am

8/9/2017 12:17 am

7/26/2017 06:17 am

7/26/2017 06:17 am

7/26/2017 06:17 am

7/18/2017 06:17 am

7/18/2017 06:17 am

7/12/2017 06:17 am

7/12/2017 06:17 am

6/15/2017 12:17 pm

6/8/2017 06:17 am

6/6/2017 06:17 am

6/6/2017 06:17 am

5/24/2017 06:17 am

5/23/2017 06:17 am